Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston.
Medical Practice Evaluation Center, Massachusetts General Hospital, Boston.
Clin Infect Dis. 2018 Jan 18;66(3):329-336. doi: 10.1093/cid/cix794.
A reported penicillin allergy may compromise receipt of recommended antibiotic prophylaxis intended to prevent surgical site infections (SSIs). Most patients with a reported penicillin allergy are not allergic. We determined the impact of a reported penicillin allergy on the development of SSIs.
In this retrospective cohort study of Massachusetts General Hospital hip arthroplasty, knee arthroplasty, hysterectomy, colon surgery, and coronary artery bypass grafting patients from 2010 to 2014, we compared patients with and without a reported penicillin allergy. The primary outcome was an SSI, as defined by the Centers for Disease Control and Prevention's National Healthcare Safety Network. The secondary outcome was perioperative antibiotic use.
Of 8385 patients who underwent 9004 procedures, 922 (11%) reported a penicillin allergy, and 241 (2.7%) had an SSI. In multivariable logistic regression, patients reporting a penicillin allergy had increased odds (adjusted odds ratio, 1.51; 95% confidence interval, 1.02-2.22) of SSI. Penicillin allergy reporters were administered less cefazolin (12% vs 92%; P < .001) and more clindamycin (49% vs 3%; P < .001), vancomycin (35% vs 3%; P < .001), and gentamicin (24% vs 3%; P < .001) compared with those without a reported penicillin allergy. The increased SSI risk was entirely mediated by the patients' receipt of an alternative perioperative antibiotic; between 112 and 124 patients with reported penicillin allergy would need allergy evaluation to prevent 1 SSI.
Patients with a reported penicillin allergy had a 50% increased odds of SSI, attributable to the receipt of second-line perioperative antibiotics. Clarification of penicillin allergies as part of routine preoperative care may decrease SSI risk.
据报道的青霉素过敏可能会影响接受推荐的抗生素预防用药,以预防手术部位感染(SSI)。大多数有报告的青霉素过敏的患者并非过敏。我们确定了报告的青霉素过敏对 SSI 发展的影响。
这是一项回顾性队列研究,纳入了 2010 年至 2014 年期间马萨诸塞州综合医院髋关节置换术、膝关节置换术、子宫切除术、结肠手术和冠状动脉旁路移植术患者,比较了有和无报告的青霉素过敏患者。主要结局是由疾病控制与预防中心的国家医疗保健安全网络定义的 SSI。次要结局是围手术期抗生素使用。
在接受 9004 例手术的 8385 名患者中,922 名(11%)报告了青霉素过敏,241 名(2.7%)发生了 SSI。多变量逻辑回归显示,报告青霉素过敏的患者 SSI 的可能性增加(调整后的优势比,1.51;95%置信区间,1.02-2.22)。青霉素过敏报告者接受的头孢唑啉(12% 比 92%;P <.001)和克林霉素(49% 比 3%;P <.001)、万古霉素(35% 比 3%;P <.001)和庆大霉素(24% 比 3%;P <.001)较少,与无报告青霉素过敏的患者相比。SSI 风险的增加完全是由于患者接受了替代围手术期抗生素;有 112 至 124 名报告青霉素过敏的患者需要进行过敏评估,以预防 1 例 SSI。
报告的青霉素过敏患者 SSI 的可能性增加了 50%,这归因于二线围手术期抗生素的使用。作为常规术前护理的一部分,澄清青霉素过敏情况可能会降低 SSI 的风险。